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ABSTRACT
Thefunctionalanddynamicalpropertiesofthehuman
topoisomerase I Thr718Ala mutant have been com-
paredtothatofthewild-typeenzymeusingfunctional
assays and molecular dynamics (MD) simulations. At
physiological ionic strength, the cleavage and religa-
tion rates, evaluated on oligonucleotides containing
the preferred topoisomerase I DNA sequence, are
almost identical for the wild-type and the mutated
enzymes, as is the cleavage/religation equilibrium.
On the other hand, the Thr718Ala mutant shows a
decreased efficiency in a DNA plasmid relaxation
assay. The MD simulation, carried out on the enzyme
complexedwithitspreferredDNAsubstrate,indicates
that the mutant has a different dynamic behavior
compared to the wild-type enzyme. Interestingly,
nochangesareobservedintheproximityofthemuta-
tion site, whilst a different flexibility is detected in
regions contacting the DNA scissile strand, such as
thelinkerandtheV-shapedahelices.Takentogether,
the functional and simulation results indicate a direct
communication between the mutation site and
regions located relatively far away, such as the linker
domain, that with their altered flexibility confer a
reducedDNArelaxationefficiency.Theseresultspro-
vide evidence that the comprehension of the topo-
isomerase I dynamical properties are an important
element in the understanding of its complex catalytic
cycle.
INTRODUCTION
Eukaryotic topoisomerase I (Top1) is a monomeric enzyme
that catalyzes the relaxation of supercoiled DNA during
important processes including DNA replication, transcription,
recombination and chromosome condensation (1–3). Human
topoisomerase I (hTop1) is composed of 765 aminoacids, and
the crystal structure of the N-terminal truncated protein
(topo70) together with proteolytic experiments have shown
that the enzyme is composed of four different domains:
N-terminal domain (residues 1–214), core domain (residues
215–635), linker domain (residues 636–712) and C-terminal
domain (residues 713–765) (4–6).
The catalytic cycle of the enzyme involves a nucleophilic
attack of the active site tyrosine (Tyr-723) on the DNA back-
bone resulting in a breakage of one DNA strand, with the
enzyme covalently attached to the 30-phosphate at the nick.
According to the ‘rotation model’, the enzyme changes the
linking number of DNA allowing the free 50-DNA substrate to
rotate around the intact strand. It has been proposed that this
rotation could be partially controlled by the linker domain and
the V-shaped a helices (a6 from core subdomain I and a5
from core subdomain II, Figure 1). A second nucleophilic
attack, driven now by the 50-hydroxylDNAend, restoresintact
DNA and frees enzyme (6).
Human topoisomerase I is of signiﬁcant medical interest
being the only target of the antitumor drug camptothecin
(CPT). CPT reversibly binds to the covalent intermediate
DNA–enzyme, stabilizing the cleavablecomplex and reducing
the rate of religation. The stalled topoisomerase I collides
with the progression of the replication fork producing lethal
double-strand DNA breaks and cell death (1,7). Recently, an
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interaction of CPT with topoisomerase I and DNA has been
provided by the crystal 3D structure of the ternary complex
between topo70 covalently linked to DNA and the CPT deriv-
ative Topotecan (8). The structure shows that the drug inter-
calates into the DNA duplex and moves the 50-hydroxyl end
of the DNA away from the scissile phosphate. This misalign-
ment of the two ends probably slows down the religation step.
Besidesthe effects on thereligationreaction, CPTbindingalso
reduces the linker domain mobility. This long-range effect
has been highlighted by the fact that the linker shows a deﬁned
electron density in the structure of the Topotecan–DNA–
topo70 ternary complex, but not in that of the DNA–topo70
binary complex (8). Moreover, the presence of the linker
domain is required for a full CPT inhibition (9) and recently
we have demonstrated that a single mutation in the linker
domain confers CPT resistance (10). Finally, it has been
also proposed that the drug effect is not limited to the slowing
of the religation, but also includes the hindering of DNA
rotation (11).
A CPT-like behavior has been proposed for the threonine
722 to alanine mutant, ﬁrst isolated in yeast by Megonigal and
coauthors(12).Thismutant,whenexpressedinSaccharomyces
cerevisiae exhibits a dramatic reduction in cell viability,
enhancing the stability of the cleavable complex, with a mech-
anism similar to the action of CPT (12). The same mutation
introduced in the corresponding residue 718 of the human
enzyme (htop1Thr718Ala) shows a similar phenotype (13).
To gain further information on the CPT inhibition mech-
anism, we have compared wild-type and htop1Thr718Ala
enzymes measuring the cleavage, relaxation and religation
steps, while the intra and inter-domain communications have
been analyzed through molecular dynamics (MD) simulation.
The data indicate that the htop1Thr718Ala mutant slows down
DNA relaxation, probably because of an altered dynamics at
the level of the linker domain and the V-shaped a helices.
MATERIALS AND METHODS
Yeast strains and plasmids
ANTI-FLAG M2 afﬁnity gel Freezer-Safer, FLAG peptide
and M2 monoclonal antibody were purchased from Sigma.
S.cerevisiae strain EKY3 (ura3-52, his3D200, leu2D1,
trp1D63, top1::TRP1, MATa was described previously
(14,15). Plasmid YCpGAL1-hTop1 in which the hTop1 is
expressed under the galactose-inducible promoter in a single
copy plasmid, has been described (15,16). htop1Thr718Ala
was generated by oligonucleotide-directed mutagenesis of
the hTop1 gene, and then cloned into BamHI–SalI-cut
pBM126 to yield YCpGAL1-htop1Thr718Ala. The epitope-
tagged construct YCpGAL1-heTOP1 contains the N-terminal
sequence DYKDDDY recognized by the M2 monoclonal
antibody. The epitope-tag was subcloned into YCpGAL1-
htop1Thr718Ala to produce YCpGAL1-hetop1Thr718Ala
(13).The oligos used forthe religation experiment were kindly
provided by Mary-Ann Bjornsti, St Jude Children’s Research
Hospital, Memphis, TN.
Purification of DNA topoisomerase I
To purify heTOP1 and heTop1Thr718Ala EKY3, cells were
transformed with YCpGAL1-heTOP1 and YCpGAL1-
hetop1Thr718Ala, grown on SC-uracil plus 2% dextrose
and diluted 1:100 in SC-uracil plus 2% rafﬁnose. At an optical
density of A595 = 1.0, the cells were induced with 2% galac-
tose for 6 h. Cells were then harvested by centrifugation,
washed with cold water and resuspended in 2 ml buffer/g
cells using a buffer containing 50 mM Tris, pH 7.4, 1 mM
EDTA, 1 mM ethylene glycol bis(b-aminoethyl ether)-
N,N,N0,N0-tetraacetic acid, 10% (v/v) glycerol completed
with protease inhibitors cocktail (Roche 1836153), and sup-
plemented with 0.1 mg/ml sodium bisulﬁte and 0.8 mg/ml
sodium ﬂuoride. After addition of 0.5 vol of 425–600 mm
diameter glass beads, the cells were disrupted by vortexing
for 30 s alternating with 30 s on ice. The lysate were centri-
fuged and KCl 0.15 M ﬁnal concentration was added to the
sample prior to loading onto 2 ml ANTI-FLAG M2 afﬁnity gel
column equilibrated as described in the technical bulletin
(Sigma). The column was washed with 20 column volumes
of Tris-buffered saline (TBS) (50 mM Tris–HCl and 150 mM
KCl, pH 7.4). Elution of FLAG-fusion-heTop1 was performed
by competition with ﬁve column volumes of a solution
containing 100 mg/ml FLAG peptide in TBS. Fractions of
500 ml were collected and glycerol 40% ﬁnal concentration
was added; all preparations were stored at  20 C. The frac-
tions were resolved by SDS–PAGE; protein concentration
and integrity were measured through immunoblot assay,
Figure 1. Topo70 hTop1 structure in complex with duplex DNA. Core Sub-
domains I, II and III are rendered in yellow, blue and red, respectively. Linker
and C-terminal domains are rendered in green and cyan, respectively. The
regioncontainingthe catalytic Tyr-723andthe mutatedThr-718is highlighted
in the insert.
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normalization to the same amount of protein, the activity of
the wild-type and mutant DNA topoisomerase I, as assayed
by relaxation of supercoiled DNA at 150 mM KCl, has been
found almost identical. In all the biochemical experiments, the
same amount of wild-type and mutated protein has been used.
DNA Top1 activity in vitro
Top1 activity was assayed with a DNA relaxation assay
(14–17). Top1 preparations were incubated in 30 ml reaction
volume containing 0.5 mg (DNA excess) or 0.05 mg (enzyme
excess) of negatively supercoiled plasmid pHC624 and reac-
tion buffer (20 mM Tris–HCl, 0.1 mM Na2EDTA, 10 mM
MgCl2,5 0mg/ml acetylated BSA and 150 mM KCl, pH 7.5).
Reactions were stopped with a ﬁnal concentration of 0.5%
SDS after 1 h at 37 C. The supercoiled pHC624 DNA, that is
present in both monomeric and dimeric forms, has been used
as substrate.The presence of these two forms permits tofollow
the relaxation efﬁciency of the enzyme with two different
substrates.
To assess the effects of ionic strength on enzyme activity,
KCl was added in the DNA relaxation assay. The reaction
was stopped with a ﬁnal concentration of 0.5% SDS, and
electrophoresis of the samples was carried out in a 1% agarose
gel. DNA was visualized by staining of the gel with ethidium
bromide and the gel image was analyzed using the Image-
Quant software. The percentage of relaxation, measured as
the amount of supercoiled plasmid converted to the relaxed
form, is plotted as a function of salt concentration.
Kinetics of religation using oligonucleotide substrate
Oligonucleotide substrate CL14 (50-GAAAAAAGACTTAG-
30) was radiolabeled with [g-
32P]ATP at its 50 end. The CP25
complementary strand (50-TAAAAATTTTTCTAAGTCTTT-
TTTC-30) was phosphorylated at its 50 end with unlabeled
ATP. The two strands were annealed at a 2-fold molar excess
of CP25 over CL14 as described (10). CL14/CP25 (20 nM)
was incubated with an excess of enzyme for 60 min at 23 C
followed by 30 min at 37 C in 20 mM Tris (pH 7.5), 0.1 mM
Na2EDTA, 10 mM MgCl2,5 0mg/ml acetylated BSA and
150 mM KCl. Once cleavage had occurred, KCl was added
to a ﬁnal concentration of 0.5 M in order to inhibit further
cleavage by the enzyme. Religation reactions were initiated
by adding a 200-fold molar excess of R11 oligonucleotide
(50-AGAAAAATTTT-30) over the duplex CL14/CP25. For
various time points at 37 C, 5 ml aliquots were removed
and the reaction was stopped with 0.5% SDS. After ethanol
precipitation, samples were resuspended in 5 ml of 1 mg/ml
trypsin and incubated at 37 C for 30 min. Samples were
analyzed by denaturing urea/PAGE. The percentage of the
remaining covalent complex (cleavage 1) was determined by
PhosphorImager andImageQuantsoftware,and normalizedon
the total amount of radioactivity in each lane. The religation
rate (kr) was determined by ﬁtting the data to the equation
ln(% remaining cleavable complex) = 4.605   krt (9).
DNA religation was also assessed using alternative methods
described by Colley et al. (18), which permits in a single
experiment to detect both cleaved and religated oligonuc-
leotides. Brieﬂy, 20 nM CL14/CP25 was incubated with a
10-fold excess of the complementary R11 religation strand
(50-AGAAAAATTTT-30) in 20 mM Tris–HCl, pH 7.5, 10 mM
MgCl2, 0.1 mM EDTA, 50 mg/ml acetylated BSA at 50 or
150 mM KCl. An identical concentration of native or mutated
enzyme was added at 25 C. Aliquots (5 ml) were taken, as
function of time, and the reaction was stopped adding 0.5%
SDS and heating up to 75 C. Reaction products were resolved
in 20% acrylamide/7 M urea gels and visualized with a
PhosphorImager. This procedure permits to well separate
the enzyme-bound cleaved oligonucleotide from the unbound
religated oligonucleotide product.
Kinetics of cleavage using oligonucleotide substrate
The duplex (CL14/CP25) substratewas generated as described
above. The suicide cleavage reactions were carried out by
incubating 20 nM of the duplex with an excess of enzyme
in 20 mM Tris (pH 7.5), 0.1 mM Na2EDTA, 10 mM MgCl2,
50 mg/ml acetylated BSA and 150 mM KCl at 23 C in a ﬁnal
volume of 50 ml as described by Yang and Champoux (19).
A5ml sample of the reaction mixture before the addition of
the protein was removed and used as the zero time point. At
various time points, 5 ml aliquots were removed and the reac-
tion stopped with 0.5% SDS. After ethanol precipitation,
samples were resuspended in 5 ml of 1 mg/ml trypsin and
incubated at 37 C for 30 min. Samples were analyzed by
denaturing urea/PAGE. The percentage of cleavage 1 was
determined by PhosphorImager and ImageQuant software
and normalized on the total amount of radioactivity in each
lane. The kinetics of cleavage was also followed through the
enzyme-bound cleaved oligonucleotide product as described
in the previous section.
Cleavage/religation equilibrium
Oligonucleotides CL25 (50-GAAAAAAGACTTAGAAAAA-
TTTTTA-30) was radiolabeled with [g-
32P]ATP at its 50 end.
The CP25 complementary strand (50-TAAAAATTTTTCTA-
AGTCTTTTTTC-30) was phosphorylated at its 50 end with
unlabeled ATP. The two strands were annealed at a 2-fold
molar excess ofCP25 over CL25.Duplex CL25/CP25(10nM)
was incubated with an excess of enzyme at 25 Ci n2 0m M
Tris, pH 7.5, 0.1 mM Na2EDTA, 10 mM MgCl2,5 0mg/ml
acetylated BSA and either 50 or 150 mM KCl. After 30 min,
the reaction was stopped adding 0.5% SDS and either heating
up to 75 C or precipitating with ethanol and digesting with
trypsin. Reaction products were resolved in 20% acrylamide/
7 M urea gels and the percentage of cleavage (%Cl) was
determined using a PhosphorImager and ImageQuant soft-
ware. The value of the cleavage/religation equilibrium
constant (Kcr) has then been calculated from the equation
Kcr = %Cl/(100   %Cl).
MD simulations
The topo70–DNA covalent complex was modeled obtaining
the starting position for residues 215–633 and 641–765 from
the crystal structure 1a36 (6), and those for residues 203–214
from the crystal structure 1ej9 (5). The seven residues con-
stituting the loop region that connects the linker to the core
domain [residues 634–640, which are lacking in the 1a36
Protein Data Bank (PDB) structure because of thermal
ﬂuctuation] and the covalent bond between Tyr-723 and the
DNA-1 base were added to the system by molecular modeling
Nucleic Acids Research, 2005, Vol. 33, No. 10 3341using the SYBYL program (Tripos Inc., St Louis, MO). The
same procedure has been followed to reconstruct the partially
missing sidechains of the residues not fully detected in the
X-ray diffraction structure. The spatial environment of each
new residue was checked for close contact or overlap with
neighboring residues, and stereochemical regularization of the
structures was obtained by the Powell minimization method
implemented in the SYBYL program. Residue 718 has been
changed from threonine to alanine to generate the mutant
topo70–DNA complex.
The systems were modeled with the AMBER95 all atom
force-ﬁeld (20), and placed in a rectangular box (127 ·
84 · 108 s
3) ﬁlled with TIP3P water molecules (21). Na
+
counterions were added to make the system electro neutral.
The resulting total systems contained 9417 protein atoms,
1401 DNA atoms, 21 Na
+ counterions and 28313 water
molecules for topo70, giving a total of 95778 atoms; and
9413 protein atoms, 1401 DNA atoms, 21 Na
+ counterions
and 28 314 water molecules for the Thr718Ala mutant, giving
a total of 95777 atoms. All the system atoms have been sub-
jected to an unconstrained simulation that allows the move-
ment of both protein and DNA atoms. Note that this large
number of atoms require efﬁcient parallel computers to be
simulated. Simulation of one of the two systems for 3250 ps
required 408 h of wall clock time on eight CPUs of the IBM
sp4 (Power4 at 1.3 GHz). The systems were simulated in
periodic boundary conditions, using a cutoff radius of 9 s
for the non-bonded interactions, and updating the neighbor
pair list every 10 steps. The electrostatic interactions were
calculated with the Particle Mesh Ewald method (22,23).
The SHAKE algorithm (24) was used to constrain all bond
lengths involving hydrogen atoms. Optimization and relaxa-
tion of solvent and ions were initially performed keeping the
solute atoms constrained to their initial position with decreas-
ing force constants of 500, 25, 15 and 5 kcal/(mol A ˚).
The systems have been simulated for 3250 ps at a constant
temperature of 300 K using Berendsen’s method (25) and at a
constant pressure of one bar with a 2 fs time step. Pressure and
temperature coupling constants were 0.5 ps. The analyses
reported in this manuscript refer to the last 3000 ps of the
trajectory (i.e. from 250 to 3250 ps), since the trend of the root
mean square deviations (RMSDs) indicates that the systems
are well stabilized after 250 ps.
The principal component analysis (26,27), the direct hydro-
gen bonds, the RMSDs and root mean square ﬂuctuations
(RMSF) have been calculated using the GROMACS MD
package version 3.1.4 (28). The water-mediated hydrogen
bondcalculation hasbeen carriedoutusinganin-housewritten
code, based on the GROMACS g_hbond code.
RESULTS
Relaxation activities of hTop1 and hTop1Thr718Ala
In order to analyze the different ionic strength requirement for
the hTop1Thr718Ala and the wild-type protein, a relaxation
plasmid assay was performed using a DNA substrate con-
stituted by a dimeric (DSC) and monomeric (MSC) form
(Figure 2A). The data plotted in Figure 2B indicate that,
with both substrates, the two enzymes have their maximum
relaxation efﬁciency in the 100–200 mM range whereas at low
salt concentration (50 mM), the mutant is more efﬁcient than
the wild-type. The different salt proﬁle shown by the wild-type
and the mutated enzyme suggests a different electrostatic
behavior. However, since the single mutation does not concern
a charged residue, this effect is probably due to different
structural–dynamical properties that modulate the interaction
with DNA. At physiological salt concentration (150 mM KCl),
the two enzymes show a maximum and comparable relaxation
activity, therefore all the results presented in this paper have
been carried out at this salt concentration.
The catalytic process of topoisomerase I is composed of
different steps such as DNA association, cleavage, strand rota-
tion, ligation and dissociation. In order to test the role played
by the association and dissociation rates, the relaxation activ-
ities of the native and mutated enzyme have been assayed
either with excess of supercoiled DNA relative to enzyme
(in a time range from 0.5 to 60 min, Figure 3A), or with excess
of enzyme compared to DNA (in a time range from 4 to 480 s,
Figure 3B). In both experimental conditions, the native
enzyme relaxes supercoiled DNA three to four times faster
than themutant.Theabsenceofanyeffectoftheenzyme/DNA
ratio on the relaxation experiments indicates that the lower
relaxation efﬁciencyofthe mutant cannot beascribedtovaried
association/dissociation rates, but must be found in the
cleavage/strand-rotation/religation steps of catalysis (29).
Cleavage and religation rate of hTop1 and
hTop1Thr718Ala
In order to understand the cleavage religation property of the
mutated enzyme, we have carried out a cleavage/religation
equilibrium experiment on a 25mer full duplex oligonuc-
leotide substrate CL25 (50-GAAAAAGACTTAGAGAAAA-
ATTTT-30)/CP25 at medium (150 mM KCl) and low (50 mM
KCl) ionic strength (Figure 4). At 150 mM KCl, the intensity
of the band due to the cleavable complex is identical for
both enzymes indicating that in this condition the enzymes
are characterized by identical cleavage/religation equilibrium
constant. In detail, evaluation of the cleavage percentage
of the labeled scissile strand using the PhosphorImager and
ImageQuant software indicates that Kcr is 2 · 10
 4 for both
enzymes.
On the other hand at 50 mM KCl, the equilibrium of the
hTop1Thr718Ala is shifted toward the cleavable complex
when compared to the wild-type enzyme. Quantitative evalu-
ation of Kcr gives a value of 3 · 10
 4 and 9 · 10
 4 for the
wild-type and the Thr718Ala mutant, respectively. A similar
behavior has been observed at 50 mM KCl for a 900 bp DNA
fragment where the Thr718Ala mutation shifted the equilib-
rium toward cleavage, as detected by the presence of several
covalent enzyme–DNA intermediates (13).
Since the cleavage/religation equilibrium constant, for a
linear DNA substrate can be deﬁned as Kcr = kcl/kr, the experi-
ment reported in Figure 4 suggests that at physiological ionic
strength, the native and mutated enzymes are characterized by
identical cleavage (kcl) and religation (kr) rates. In order to
verify that the identical equilibrium constant is not due to an
identical variation of the cleavage and religation rate, the
cleavage chemical step has been investigated using a 50 end
radiolabeled suicide substrate CL14 (50-GAAAAAAGACT-
T
#AG-30), containing the preferred Top1 sequence (marked
3342 Nucleic Acids Research, 2005, Vol. 33, No. 10by the arrow), annealed to the CP25 (50-TAAAAATTTTTC-
TAAGTCTTTTTTC-30) complementary strand, to produce
a duplex with an 11-base 50 single-strand extension. With
this substrate, the religation step is excluded because the
short oligonucleotide (AG-30) generated during cleavage
cannot be religated, leaving the enzyme covalently attached
to the 12 oligonucleotide 30 end (9). The suicide cleavage
substrate has been incubated with an excess of hTop1 or
hTop1Thr718Ala in a time course experiment. The amount
of cleaved fragment, normalized to the plateau value of the
hTop1, has been plotted as a function of time in Figure 5A.
Data show that both enzymes have an almost identical cleav-
age rate (kcl), reaching in a comparable time a plateau that,
however, has a lower value for the hTop1Thr718Ala mutant.
Any quantitative evaluation of kcl from the slope of the ﬁrst
part of the curve has been unsuccessful due to the paucity of
experimental points present in this region.
DNA religation step has then been studied by testing the
ability of both enzymes to religate the oligonucleotide R11
(50-AGAAAAATTTT-30) added to the cleaved suicide sub-
strate. The ﬁrst step of the assay consists in the incubation of
an excess of hTop1 or hTop1Thr718Ala with the suicide sub-
strate for 60 min in order to generate the cleaved complex with
the enzyme covalently attached to the 30 end. Once cleavage
has occurred, the salt concentration is raised to 0.5 M KCl to
prevent further cleavage activity by the enzyme (19) and the
R11 oligonucleotide is then added to the mixture to initiate
the ligation process. Aliquots have been removed at different
Figure 2. (A)RelaxationofnegativesupercoiledplasmidDNAofpurifiedhTop1(lanes1–8)andhTop1Thr718Ala(lanes9–16)atKClconcentrationsof0,50,100,
150,200,250,300and350mM.Reactionproductswereresolvedinanagarosegelandvisualizedbyethidiumbromidestaining.Thedimericandmonomericformsof
the supercoiled plasmid DNA are indicated by ‘DSC’ and ‘MSC’, respectively. Lane C, no protein added. (B) Percentage of relaxation measured as the amount of
monomeric (squares) and dimeric (circles) supercoiled plasmid converted to the relaxed form by hTop1 (full line) and hTop1Thr718Ala (dotted line), plotted as a
function of salt concentration.
Nucleic Acids Research, 2005, Vol. 33, No. 10 3343times, the reaction stopped by addition of SDS and the pro-
ducts analyzed by PAGE. The percentage of the remaining
cleaved complex,determinedasdescribedunder Materials and
Methods, plotted as a function of time in Figure 5B indicates
that hTop1 and hTop1Thr718Ala have very similar religation
rates (kr), their values, evaluated from the decay of the curve,
being equal to 0.14 and 0.19 min
 1, respectively. The identity
of the religation rate, kr, and of the cleavage/religation equi-
librium, Kcr, indicates that the chemistry of the enzyme at
150 mM KCl is identical for both the wild-type and the
mutated enzyme and that these steps of the enzymatic reaction
cannot be the origin of the reduced relaxation efﬁciency of
the mutant.
The cleavage and religation efﬁciency of the wild-type and
mutated enzyme has been also tested in a single experiment
using the procedure described by Colley et al. (18) at two
different ionic strengths, namely at 50 and 150 mM KCl.
At 150 mM KCl, hTop1 and hTop1Thr718Ala display a
similar behavior, in agreement with the previously described
experiments (Figure 5) characterized by an almost equal
cleavage and religation rate. On the other hand at low ionic
strength(50mM KCl),the mutated enzymeischaracterizedby
higher cleavage efﬁciency and by lower religation efﬁciency
when compared to the wild-type enzyme (data not shown). In
line, a recent work has shown that the yeast topoisomerase
I mutant Thr722Ala (corresponding to the Thr718Ala in the
human enzyme) displays a decreased religation rate compared
to the wild-type protein, when measured at50 mM KCl on a 36
oligonucleotide DNA substrate (18).
Root mean square deviations and fluctuations
The experiments described above indicate that upon the single
Thr718Ala mutation, the chemistry of the enzyme is unaltered
and the relaxation efﬁciency is reduced. This suggests that the
main effect caused by the mutation as detected by experiments
carried out at 150 mM KCl ionic strength is a perturbation
in the dynamical behavior that alters the control of the DNA
Figure 3. RelaxationkineticsforhTop1andhTop1Thr718Alaattheirsaltoptimaconcentrations.(A)PurifiedhTop1(lanes1–8)andhTop1Thr718Ala(lanes9–16)
were incubated with 0.5 mg/ml supercoiled plasmid DNA for 0.5, 1, 2, 4, 8, 15, 30 and 60 min at 37 C at 150 mM KCl. (B) Purified hTop1 (lanes 1–8) and
hTop1Thr718Ala(lanes9–16)wereincubatedwith0.05mg/mlsupercoiledplasmidDNAfor4,8,15,30,60,120,240,480sat37 Cat150mMKCl.Thedimericand
monomeric forms of the supercoiled plasmid DNA are indicated by ‘DSC’ and ‘MSC’, respectively. Lane C, no protein added.
3344 Nucleic Acids Research, 2005, Vol. 33, No. 10strand rotation. In order to sample the dynamical properties of
the mutated enzyme, to be correlated with the above reported
experimental ﬁndings, we have carried out a 3250 ps long MD
simulation of the mutated system, and compared it with an
identical simulation carried out on the native enzyme (30).
The RMSD of the native and mutated proteins calculated as
a function of simulated time after a mass-weighted superposi-
tion on the starting structure is reported in Figure 6A, in black
and red colors respectively. The data show that the RMSD of
the whole proteins (full lines) oscillates strongly with devi-
ation peaks >3 s. Upon elimination of the linker domain
in the analysis, the RMSD of the core and C-terminal domains
(dotted lines) reach a plateau at  2 s after  250 ps for both
enzymes, and remains constant around this value for the whole
simulation time. This result indicates that in both enzymes the
linker is the most ﬂexible domain, although to a larger extent
for the native protein as will be conﬁrmed in the following
sections, and that the systems are well stabilized after 250 ps.
Therefore,allthefollowinganalysesrefertothelast3000psof
the trajectory (i.e. from 250 to 3250 ps).
The RMSF of the two simulated systems are represented in
Figure 6B, as a function of residue number. The Thr718Ala
mutant shows a reduction of ﬂuctuations in residues 674–691
ofthelinker(i.e.theloopconnecting helices18and19,andthe
entire helix 19) and an increase in the whole core subdomain
II. The data indicate that the main differences do not occur in
proximity of the mutation, where actually the ﬂuctuations of
the native and mutated enzymes are almost identical, but that
the Thr718Ala mutant induces dynamical changes in regions
contacting the DNA scissile strand.
Principal component analysis
In order to highlight the changes in protein–protein commu-
nications induced by the mutation, the principal component
Figure 4. Cleavage/religation equilibrium of DNA oligonucleotide substrate.
Lanes 1 and 2 refer to hTop1 protein incubated at 50 and 150 mM KCl
respectively with the [g-
32P] end-labeled duplex DNA shown at the top of
the figure, where the arrow indicates the preferential cleavage site. Lanes 3
and 4 show the same incubation with hTop1Thr718Ala. The asterisk indicates
the band corresponding to the preferential cleavage site. Lane C, no protein
added.
Figure 5. (A) Kinetics of cleavage determined by the percentage of the
cleaved DNA fragment plotted against time for the hTop1 (filled circles)
and hTop1Thr718Ala (filled squares). All values are the average of three
different experiments normalized to the plateau of the wild-type enzyme.
(B) Kinetics of religation determined by the percentage of the remaining
covalent complex plotted against time for the hTop1 (filled circles) and
hTop1Thr718Ala (filled squares). All values are the average of three different
experiments, upon normalization at t = 0.
Nucleic Acids Research, 2005, Vol. 33, No. 10 3345Figure 6. Rootmeansquaredeviations(RMSD)andfluctuations(RMSF).(A)ProteinRMSDfromthestartingstructurearerepresentedasafunctionofsimulation
timeinblackandredfulllinesforthewild-typeandThr718Alamutant,respectively.ThecoreandC-terminaldomainRMSDarerepresentedinblackandreddotted
linesforthewild-typeandThr718Alamutant,respectively.(B)TheperresidueRMSFarerepresentedasafunctionoftheresiduenumberinblackandredlinesforthe
wild-type and Thr718Ala mutant, respectively.
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enzyme trajectories to identify the main 3N directions along
which the majority of the protein motion is deﬁned (26,27).
This analysis is based on the diagonalization of the covariance
matrix built from the atomic ﬂuctuations after the removal
of the translational and rotational movement, and it has
been carried out on the 563 Ca atoms of the protein. The
displacement of each Ca along the ﬁrst eigenvector having
the largest eigenvalue shown in Figure 7A, indicates that the
linker domain is the protein region with the maximum dis-
placement along this direction for both systems, but with an
absolute value larger for the wild-type than for the mutated
enzyme. The larger linker ﬂuctuations in the wild-type can
be better appreciated looking at the projections of the MD
Figure 7. (A)DisplacementsofeachCaatomalongtheeigenvectorwiththelargesteigenvalue(firsteigenvector)arerepresentedinblackandredlinesforthewild-
typeandThr718Alamutant,respectively.RepresentationoftwoextremeprojectionsoftheMDmotionsalongthefirsteigenvectorforthewild-typeprotein(B)and
mutant proteins (C). Black arrows indicate the amplitude and the direction of the motion.
Nucleic Acids Research, 2005, Vol. 33, No. 10 3347motions along the ﬁrst eigenvector for the wild-type and
mutant proteins shown in Figure 7B and C, respectively.
Note that the projections of the protein motions have been
represented together with the average protein–DNA structures
calculated from the fully unconstrained simulations. Figure 7
also shows an increase in the mutant Ca displacement in the
whole core subdomain II and the N-terminal portion of core
subdomain I (Figure 7A). The two extreme projections of
the MD motions along the ﬁrst eigenvector illustrate how
the motions of the V-shaped a6 from core subdomain I and
a5 from core subdomain II are strongly increased upon the
Thr718Ala mutation (Figure 7B and C). The principal com-
ponent analysis indicates that the regions more altered in their
dynamicsasaresultofthe single mutation are thosecontacting
the DNA scissile strand, which probably play a role during the
DNA relaxation process. A dynamic visualization of the MD
projections along the ﬁrst three eigenvectors are available at
NAR Online.
Hydrogen bonds in the mutation site region
As a ﬁnal analysis, we have calculated the network of
the protein–DNA and protein–protein hydrogen bonds, in the
proximity of the mutation site. A MD conformation of
the Thr718Ala mutant in the proximity of the mutation site,
representing the hydrogen bond network formed by the
enzyme during the simulation, is shown in Figure 8. The
picture shows the involvement of Ala-718 in direct and
water-mediated hydrogen bonds with the protein and DNA,
respectively.
A hydrogen bond between the side chain of Thr-718 and the
G+2 phosphate group of the scissile strand has been detected
in several crystallographic structures of topo70 (PDB id 1a36,
1k4s, 1k4t) (6–8). This bond has been proposed to play an
important role in the orientation of the +15 0-OH group during
the nucleophilic attack in the religation step (8). The topo70–
DNA complex simulation conﬁrms the importance of the
Thr-718–G+2bond, beingpresent during the whole simulation
time (data not shown). This hydrogen bond is obviously absent
in the Thr718Ala mutant because of the lack of the threonine
side chain and analysis of the trajectory indicates that the
backbone of alanine forms a direct hydrogen bond with the
G+2 phosphate group for only 3% of the simulation time.
However, the absence of a direct bond between the Ala-718
and the G+2 base is compensated by a highly stable water-
mediated hydrogen bond, present for 95% of the simulation
time (Figure 8). In the wild-type enzyme, a similar bond is
lacking and a water-mediated hydrogen bond between the side
chain of Thr-718 and the G+2 base is present only for 18% of
the simulation time.
Deletion of the side chain of Thr-718 also induces changes
in the local network of protein–protein hydrogen bonds. In the
wild-type enzyme, Thr-718 forms direct hydrogen bonds
through its side chain with His-632 and Ser-517, for 43 and
41% of the simulation time respectively, and through its
backbone with Leu-721 and Asn-722, for 19 and 23% of the
simulation time, respectively (data not shown). In the mutated
enzyme, the backbone of Ala-718 forms direct hydrogen
bonds with Leu-721 and Asn-722, for 66 and 99% of the
simulation time respectively, and with the catalytic Tyr-723
for 18% of the simulation time.
CONCLUSIONS
The results presented here show that at 150 mM KCl the
Thr718Ala mutant has a DNA relaxation rate lower than
the wild-type enzyme (Figure 3) even though the cleavage/
religation equilibrium (Figure 4), the religation rate
(Figure 5B) and then the cleavage rate (Figure 5A) are com-
parable to those of the wild-type enzyme when using as sub-
strate a short linear oligonucleotide containing the preferred
cleavage site. A direct comparison between the relaxation rate
(Figure 3) and the cleavage and religation rates (Figure 5) is
made impossible by the requirement of different substrates
in the two sets of experiment, i.e. a supercoiled DNA substrate
made by thousands of base pairs in the relaxation experi-
ment and a DNA linear substrate containing 25 bp in the
cleavage and religation experiments. On the other hand, the
cleavage and religation experiments (Figure 5) can be more
directly compared with the equilibrium experiment (Figure 4)
since a linear substrate is used in both cases. At physiological
ionic strength, the wild-type and mutated enzyme have an
identical equilibrium (Figure 4), as well as an identical religa-
tion rate (Figure 5B) indicating that at this ionic strength,
the reduced relaxation rate of the Thr718Ala mutant is not
due to a decreased religation rate but to a lower DNA binding
Figure 8. Percentage of hydrogen bonds in the mutation site region evaluated
from the MD trajectory. Protein residues and bases are highlighted in cyan and
purple, respectively. The oxygen and nitrogen atoms involved in the hydrogen
bondsarehighlightedwithredandbluespheres,respectively.Directandwater-
mediated hydrogen bonds are represented in black full and dotted lines,
respectively, together with the percentage of their lifetime in the simulation
trajectory.
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experiments reported in Figure 3 show a decreased relaxation
efﬁciency of the mutant when compared to the wild-type,
independent of the DNA/enzyme ratio. This result excludes
that the difference in DNA relaxation between the two pro-
teins can be ascribed to the enzyme substrate association/
dissociation rate, implying that the main effect of the single
Thr718Ala mutation is associated to the rotation step of the
catalysis (29). The in vitro biochemical results then provide
unambiguous evidences that at physiological ionic strength,
the main functional difference between the native and the
Thr718Ala mutated Top1 is conﬁned to their strand rotation
that is lower for the mutated enzyme.
The MD simulation furnishes an explanation for such an
experimental behavior providing structural/dynamical data
that permit to interpret the identical religation rate and the
difference in the strand rotation. The identical religation
rate of the wild-type and the mutated enzyme is actually an
unexpected result since it has been suggested that Thr-718
plays a role in the right positioning of the 50 end through a
hydrogen bond between the aminoacidic hydroxyl group and
the G+2 phosphate group of the scissile strand (8). The MD
trajectory conﬁrms the importance of this hydrogen bond since
it is present in the native enzyme for the entire duration of the
simulation (30). However, the simulation also shows that upon
mutation of the threonine in alanine the lack of the direct
hydrogen bond with the G+2 phosphate group is compensated
by a water-mediated hydrogen bond to the backbone of
Ala-718 (Figure 8). The lack of a similar bond in the wild-
type trajectory suggests either that in the mutant, the water-
mediated bond plays a main role in the right positioning
of the 50 end, or that Thr-718 does not play any role in the
religation rate.
The MD simulation also permits to explain how the muta-
tion of a residue such as Thr-718, which is relatively close to
the catalytic site, may have a large effect on the strand rotation
step of the catalysis. The plot of the RMSF in fact, indicates
that in proximity of the mutation site the two enzymes have
identical ﬂuctuations, and that the main differences are local-
ized in the linker domain and in core subdomain II that are
supposed to be involved in the DNA strand rotation (6)
(Figure 6B). The principal component analysis conﬁrms the
RMSF results, showing that, in the mutant, the linker domain
and the V-shaped helices are the regions with the major dis-
placement along the ﬁrst eigenvector (Figure 7).
DNA strand rotation is actually strongly dependent on the
enzyme conformation and dynamics. It has been reported that
the clamp of the enzyme around DNA crosslinking residue
His-367 and Ala-499 still permits strand rotation, but this is no
longer possible when the crosslink is made between Gly-365
and Ser-534 (31,32). The fundamental role of the linker
domain in modulating the strand rotation has been demon-
strated by Champoux and co-workers (9), showing that
this domain is required for an efﬁcient CPT inhibition. The
increased mobility of the linker has been shown to be the most
likely explanation for the CPT resistance displayed by the
mutant in which alanine at 653 is substituted with a proline
(10). Multiple mutations in the linker domain render the
enzyme hypersensitive to the drug, indicating the occurrence
of protein communications between this domain and the
drug binding pocket (33). Finally, a direct correlation between
inhibitor and linker mobility has been shown upon a
comparison of the electron density maps of the enzyme
crystals in the presence or absence of Topotecan (8).
Here, we show the existence of a direct communication
between two regions located far away, i.e. the region close
to the active site and the linker domain. In fact, the Thr718Ala
mutation induces different ﬂexibility in the linker and in the
V-shaped a helices (Figures 6B and 7), conﬁrming the inter-
esting correlation betweenlinker mobility andDNA relaxation
efﬁciency. Moreover, the experimental data show that strand
rotation is an important step in the catalytic process and that
is directly controlled by the enzyme. In line, a recent report
measuring real-time single-molecule DNA relaxation has
shown that Top1 releases DNA supercoils by a swivel mech-
anism that involves friction between the rotating DNA and the
enzyme, underlining the importance of the enzyme dynamic
properties (34).
Taken together, these results indicate that for topoisomerase
I the description of the structural/dynamical properties are an
important achievement to fully understand its function and
must be taken into account for the design of new drugs
with improved efﬁciency.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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